INSIGHT - Summer 2020

Summer 2020 | 19 allenges Associated There have also been alerts from Prime Therapeutics ® and Express Scripts ® that state they will resume audits in June; however, onsite audits will continue to be virtual until further notice. Please see the notes below for things to consider in case of an onsite audit notice. PAAS Notes y Pharmacies are not able to deny participation in an audit. y Pharmacies should contact the auditor to request that any onsite audits be converted into a remote/desk audit whenever possible to reduce exposure risks. y Members are encouraged to notify PAAS National at 608.873.1342 or info@ paasnational.com , if they run into problems. PAAS can help them get in touch with audit managers, when appropriate. y If onsite audits cannot be avoided: − Request an unmasked list in advance, so pharmacy staff can pull documentation before audit day. − Require auditor to report any symptoms and take temperature prior to entering your pharmacy. − Refuse entry based on evidence of illness and request alternate accommodations. − Require auditor to wear a face mask at all times (based on CDC recommendations). − Designate an isolated workspace where a pharmacy employee can assist the auditor in efficient document retrieval to expedite the audit process. − Do not allow auditor to move about the pharmacy and offer to present any necessary materials to complete the audit (e.g., fridge temp log and sample of stock inventory). For more information, call 888.870.7227 toll free or visit paasnational.com . Sources: 1 HHS Statements on Authorizing Licensed Pharmacists to Order and Administer COVID-19 Tests. U.S. Department of Health & Human Services. 4/8/2020. Web. Accessed 6/20/20. www.hhs.gov/about/ news/2020/04/08/hhs-statements-on- authorizing-licensed-pharmacists-to-order- and-administer-covid-19-tests.html 2 Advisory Opinion 20-02 on The Public Readiness and Emergency Preparedness Act and The Secretary’s Declaration Under The Act. 5/19/20. Web. Accessed 6/20/20. www.hhs.gov/sites/default/files/advisory- opinion-20-02-hhs-ogc-prep-act.pdf